First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
News published by Renovion Inc. concerning ARINA-1, a nebulized therapy in patients with a lung transplant, administered via an optimized investigational eFlow® Technology nebulizer.